US Patent Issued to Boehringer Ingelheim International on April 14 for "Antibodies to connective tissue growth factor (CTGF) and uses thereof" (German, American Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,770, issued on April 14, was assigned to Boehringer Ingelheim International GmbH (Ingelheim am Rhein, Germany).

"Antibodies to connective tissue growth factor (CTGF) and uses thereof" was invented by Andreas-David Brunner (Mittelbiberach, Germany), Lars Dittus (Mittelbiberach, Germany), Priyanka Gupta (Newtown, Conn.), Muriel Lize (Ulm, Germany), Maria Bonatsakis Myzithras (Sandy Hook, Conn.), Irina Rybina (Sleepy Hollow, N.Y.), Julia Sauer (Biberach, Germany), Wioletta Anna Skronska-Wasek (Biberach, Germany) and Heiko Friedrich Stahl (Biberach, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure generally relates to anti-...